Drugs / Hypericin
Hypericin
also known as
HIPERICIN · HIPERICIN BATCH 867911 MS 1.1860.0003.003-0 · HyBryte · HYPERICIN SODIUM · Hypericina · Hypericine · Hypericum red · NSC-407313 · +1 more
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00000792 | ? → Jan 1995 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00000645 | ? → Oct 1994 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT06149247 | Dec 2023 → May 2024 | mycosis fungoides | Soligenix | Completed | No outcome recorded |
| Phase 2 | NCT05872854 | Aug 2023 → Dec 2025 | mycosis fungoides | Ellen Kim, MD | Completed | No outcome recorded |
| Phase 2 | NCT05442190 | Dec 2022 → Oct 2025 | psoriasis | Soligenix | Completed | No outcome recorded |
| Phase 2 | NCT05380635 | May → Aug 2022 | mycosis fungoides | Soligenix | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06470451 | Jan 2025 → May 2026 | mycosis fungoides | Soligenix | Terminated | No outcome recorded |
| Phase 3 | NCT01365676 | Mar → Oct 2012 | premenstrual tension, uterine disorder | Phytopharm Consulting Brazil | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02448381 Comparator | Dec 2015 → Jun 2020 | primary cutaneous T-cell lymphoma | Soligenix | Completed | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypericin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05872854 ↗ |
| Known as | HIPERICIN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01365676 ↗ |
| Known as | HIPERICIN BATCH 867911 MS 1.1860.0003.003-0 | “HIPERICIN® BATCH 867911 MS 1.1860.0003.003-0” NCT01365676 ↗ |
| Known as | HyBryte | “HyBryte” NCT05872854 ↗ |
| Known as | HYPERICIN SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL286494 ↗ |
| Known as | Hypericina | ChEMBL registry synonym — accepted as the source's own label CHEMBL286494 ↗ |
| Known as | Hypericine | ChEMBL registry synonym — accepted as the source's own label CHEMBL286494 ↗ |
| Known as | Hypericum red | ChEMBL registry synonym — accepted as the source's own label CHEMBL286494 ↗ |
| Known as | NSC-407313 | ChEMBL registry synonym — accepted as the source's own label CHEMBL286494 ↗ |
| Known as | SGX301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02448381 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “2 phytomedicines already in the market: GAMALINE® for premenstrual syndrome and HIPERICIN® as antidepressant will be prescribed together for treating women with Premenstrual...” NCT01365676 ↗ |
| Route | Intravenous | “receives a given dose of hypericin by intravenous infusion” NCT00000645 ↗ |